Hanna Dilenko

Hanna Dilenko

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2024 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HDHanna Dilenko
Hanna Dilenko
KTKaterina Tomankova
Katerina Tomankova
LVLucie Válková
Lucie Válková
BHBarbora Hošíková
Barbora Hošíková
MKMarketa Kolarikova
Marketa Kolarikova
HKHana Kolářová
Hana Kolářová
Photodynamic therapy (PDT) is a non-invasive therapy that has made significant progress in treating different diseases, including cancer, by utilizing new nanotechnology products such as graphene and its derivatives. Graphene-based materials have large surface area and photothermal effects thereby making them suitable candidates for PDT or photo-active drug carriers. The remarkable photophysical properties of graphene derivates facilitate the efficient generation of reactive oxygen species (ROS) upon light irradiation, which destroys cancer cells. Surface functionalization of graphene and its materials can also enhance their biocompatibility and anticancer activity. The paper delves into the distinct roles played by graphene-based materials in PDT such as photosensitizers (PS) and drug carriers while at the same time considers how these materials could be used to circumvent cancer resistance. This will provide readers with an extensive discussion of various pathways contributing to PDT inefficiency. Consequently, this comprehensive review underscores the vital roles that graphene and its derivatives may play in emerging PDT strategies for cancer treatment and other medical purposes. With a better comprehension of the current state of research and the existing challenges, the integration of graphene-based materials in PDT holds great promise for developing targeted, effective, and personalized cancer treatments.

28 April 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
HDHanna Dilenko
Hanna Dilenko
KTKaterina Tomankova
Katerina Tomankova
EHElizabeth Hinde
Elizabeth Hinde
LVLucie Válková
Lucie Válková
MKMarketa Kolarikova
Marketa Kolarikova
HKHana Kolářová
Hana Kolářová
Many photosensitive substances suitable for photodynamic therapy (PDT) have limited applications due to their insufficient solubility in polar solvents. Our research overcomes this challenge by means of nanotechnology in order to transform hydrophobic compounds into stable aqueous solutions, enabling them to use their full potential and unique properties in cancer therapy. In this study, the novel nano-composite cGQDs-PEG-curcumin was developed to overcome the insolubility of curcumin in water and its extraordinary efficacy in PDT was evaluated. Complex characterization was performed using high-resolution transmission electron microscopy (HR-TEM), FTIR, and UV-Vis spectroscopy. Further analysis involved fluorescence lifetime imaging (FLIM), and its cellular localization was mapped with confocal microscopy. In order to evaluate PDT effectiveness, cells treated with cGQDs-PEG-curcumin were irradiated with 5 J/cm2 of 414 nm light. After irradiation, cell viability assay, scanning electron microscopy (SEM), reactive oxygen species (ROS) detection, comet assay, and γH2AX-based DNA double-strand breaks (DSBs) detection were assessed and revealed a remarkable ability of the nano-composite to induce DNA damage after irradiation without ROS production. Our findings highlight the potential of cGQDs-PEG-curcumin as a cutting-edge PDT agent, capable of disrupting cell membrane and nucleolar integrity and impairing ribosomal synthesis, which is crucial for proliferating tumour cells.

Verified
Journal Article
Open access
PDF file
JHJakub Hosik
Jakub Hosik
BHBarbora Hosikova
Barbora Hosikova
SBSvatopluk Binder
Svatopluk Binder
RLRene Lenobel
Rene Lenobel
MKMarketa Kolarikova
Marketa Kolarikova
HKHana Kolarova
Hana Kolarova
This work presents results on the efficiency of newly designed zinc phthalocyanine-mediated photodynamic therapy of both tumoral and nontumoral cell models using the MTT assay. Further detailed examinations of mechanistic and cell biological effects were focused on the HELA cervical cancer cell model. Here, ROS production, changes in the mitochondrial membrane potential, the determination of genotoxicity, and protein changes determined by capillary chromatography and tandem mass spectrometry with ESI were analyzed. The results showed that, in vitro, 5 Jcm−2 ZnPc PDT caused a significant increase in reactive oxygen species. Still, except for superoxide dismutase, the levels of proteins involved in cell response to oxidative stress did not increase significantly. Furthermore, this therapy damaged mitochondrial membranes, which was proven by a more than 70% voltage-dependent channel protein 1 level decrease and by a 65% mitochondrial membrane potential change 24 h post-therapy. DNA impairment was assessed by an increased level of DNA fragmentation, which might be related to the decreased level of DDB1 (decrease in levels of more than 20% 24 h post-therapy), a protein responsible for maintaining genomic integrity and triggering the DNA repair pathways. Considering these results and the low effective concentration (LC50 = 30 nM), the therapy used is a potentially very promising antitumoral treatment.

5 November 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
KTKaterina Tomankova
Katerina Tomankova
HDHanna Dilenko
Hanna Dilenko
RVRenata VečeřOvá
Renata VečeřOvá
AHAdéla Hanáková
Adéla Hanáková
LVLucie Válková
Lucie Válková
HKHana KolářOvá
Hana KolářOvá
Curcumin, a natural polyphenolic pigment, has gained significant attention due to its potent antimicrobial properties. However, its applications are limited by poor solubility and bioavailability. Conjugation with an appropriate nanocarrier can enhancing curcumin's therapeutic efficacy. Carboxylated graphene quantum dots (cGQDs) were chosen as the nanocarrier. cGQDs were functionalized with polyethylene glycol (PEG) and curcumin, resulting in the cGQDs-PEG-curcumin nanocomposite. The antimicrobial photodynamic therapy (aPDT) efficacy of the cGQDs-PEG-curcumin was evaluated against both Gram-positive and Gram-negative bacterial strains, including resistant variants. The cGQDs-PEG-curcumin nanocomposite demonstrated significant antimicrobial efficacy under light activation, particularly against Gram-positive bacterial strains, including resistant ones (Staphylococcus aureus MIC 3.5 µM, MBC 15 µM, Enterococcus faecalis MIC 0.94 µM, MBC 3.75 µM). It also has an effect on Gram-negative bacterial strains (Escherichia coli MIC 30 µM, MBC -). Among resistant strains, the highest efficacy was observed against vancomycin-resistant Enterococcus faecium (MIC 3.75 µM and MBC 3.75 µM) and rez. P. aeruginosa (MIC 15 µM and MBC 30 µM) upon irradiation at 5 J/cm2. When double irradiation (2 ×5 J/cm2) was applied, both MIC and MBC values decreased for all tested Gram-positive bacterial strains. Binding curcumin to GQDs overcame the biological barrier posed by its poor water solubility. The synthesized nanocomposite accumulated in the bacterial cell wall, and upon light activation, induced rapid bacterial cell death immediately after irradiation, remarkably without generating reactive oxygen species (ROS). Overall, the cGQDs-PEG-curcumin nanocomposite, as a novel third-generation photosensitizer, demonstrates significant potential for aPDT, with a promising ability to overcome bacterial resistance.

22 November 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MKMarketa Kolarikova
Marketa Kolarikova
BHBarbora Hosikova
Barbora Hosikova
KLKateřina Langová
Kateřina Langová
ABAleš Benda
Aleš Benda
DPDalibor Panek
Dalibor Panek
HKHana Kolarova
Hana Kolarova
This study investigates liposomes as a CD-44-targeted delivery system with bound porphyrinic photosensitizer TMPyP using high molecular weight sodium hyaluronate (HA) for cancer cell targeting to enhance photodynamic therapy outcomes. The effects of TMPyP in its free and liposomal forms are assessed on HeLa and NIH3T3 cells, focusing on intracellular accumulation, oxidative stress, metabolic disruption, and DNA damage. DNA damage, evaluated through γ-H2AX immunofluorescence, indicates double-stranded breaks (DSBs). Free TMPyP causes DSBs in NIH3T3 cells, while liposomal TMPyP promotes a repair mechanism, shown by reduced γ-H2AX. These results are supported by cytotoxicity assays, ROS production, mitochondrial membrane potential depolarization, cytochrome C release and caspase-8 activity, indicating a possible extrinsic apoptotic pathway. The cell death analysis shows that, unlike liposomal TMPyP, free TMPyP damages NIH3T3 cells. Colocalization analysis revealed higher free TMPyP accumulation in the mitochondria of NIH3T3 cells, whereas liposomal TMPyP predominantly accumulates in the mitochondria of HeLa cells. The FLIM analysis reveals shifts in mitochondrial and nuclear NAD(P)H and FAD lifetimes, supporting the nonspecific effects of free TMPyP and highlighting the advantages of its liposomal form. These findings suggest that liposomes composed of cardiolipin, DPPC, and cholesterol with bound HA can selectively deliver TMPyP to HeLa cells for effective PDT.

Verified
Journal Article
Open access
PDF file
LVLucie Válková
Lucie Válková
MKMarketa Kolarikova
Marketa Kolarikova
RBRobert Bajgar
Robert Bajgar
RVRenata Večeřová
Renata Večeřová
KTKaterina Tomankova
Katerina Tomankova
HKHana Kolarova
Hana Kolarova
Antimicrobial photodynamic therapy is a method that utilizes photodynamic inactivation of microorganisms exposed to a photosensitizer irradiated by a specific wavelength, followed by the formation of reactive oxygen species and subsequent oxidative stress. In contrast to antibiotics, which are generally efficient against specific microorganisms, photodynamic inactivation exhibits efficacy against a wide range of bacteria, representing a promising and non-invasive alternative to treating infections caused by pathogens of different origins. This study compares the antibacterial efficacy of five different photosensitizers, including TMPyP, Protoporphyrin IX, PdTPPS4, Methylene Blue, and ZnPCS2, against eight representatives of various pathogens, including Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa, Gram-positive bacteria Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus faecalis, Enterococcus faecium, MRSA and Bacillus subtilis. An optimal irradiation protocol was developed based on growth curve measurements involving double irradiation. To induce the photodynamic effect, we utilized LED emitters with wavelengths of 414 nm and 660 nm, chosen to align with the photophysical properties of the photosensitizers. Additionally, the research included assessments of the radiation’s phototoxicity and the photosensitizers’ dark toxicity against specific microorganisms. The optical properties of the photosensitizers were analyzed using absorption spectrophotometry. The effectiveness of photodynamic inactivation was assessed by determining the minimum inhibitory and bactericidal concentrations. This study aimed to identify the most suitable photosensitizer for clinical application, considering the toxicity of the photosensitizer, the radiant exposure, and its efficacy in photodynamic inactivation.